Published in Diabetes Obes Metab on May 19, 2009
Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings. Drugs (2012) 0.91
Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus. Drug Des Devel Ther (2014) 0.81
High-mix insulins. Indian J Endocrinol Metab (2015) 0.79
Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement. Indian J Endocrinol Metab (2011) 0.77
Systematic literature review of use of blood glucose monitoring in phase III clinical studies of insulin analogs. BMC Endocr Disord (2016) 0.75
6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia. Diabetes Technol Ther (2013) 0.75
Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations. Diabetes Ther (2017) 0.75
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia (1983) 4.48
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
The CRY1 blue light photoreceptor of Arabidopsis interacts with phytochrome A in vitro. Mol Cell (1998) 2.30
Transcriptomes of the major human pancreatic cell types. Diabetologia (2011) 1.90
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89
Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia (1980) 1.71
Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet (1989) 1.63
Cryptochrome blue-light photoreceptors of Arabidopsis implicated in phototropism. Nature (1998) 1.62
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study. Diabet Med (2005) 1.53
Dose-response effects of free fatty acids on amino acid metabolism and ureagenesis. Acta Physiol (Oxf) (2007) 1.52
Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men. Clin Endocrinol (Oxf) (2001) 1.50
Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia (1981) 1.46
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer. Ann Surg Oncol (2009) 1.45
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia (1992) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) (1993) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.37
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol (1997) 1.31
Fast glycosylation of haemoglobin. Lancet (1979) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia (1981) 1.24
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Letter: Diagonal ear-lobe crease in coronary heart disease. N Engl J Med (1975) 1.18
Reduced sweating in adults with growth hormone deficiency. Lancet (1989) 1.16
Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes (2006) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Renal function in streptozotocin-diabetic rats. Diabetologia (1981) 1.13
Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol Endocrinol Metab (2002) 1.12
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism (1994) 1.12
Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes (1983) 1.12
Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes. Diabetes (1988) 1.11
Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia (1984) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care (1998) 1.06
Detection of growth hormone abuse in sport. Growth Horm IGF Res (2007) 1.05
Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int (1982) 1.05
Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes (2001) 1.05
Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Glucose monitoring by microdialysis: performance in a multicentre study. Diabet Med (2009) 1.04
Examining the Behaviour subscale of the Hypoglycaemia Fear Survey: an international study. Diabet Med (2013) 1.04
Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. J Clin Endocrinol Metab (2011) 1.03
Fast glycosylation of hemoglobin. Lancet (1979) 1.03
Weight beneficial treatments for type 2 diabetes. J Clin Endocrinol Metab (2011) 1.03
Growth hormone administration by means of an injection pen. Pharmacol Toxicol (1989) 1.03
GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab (2001) 1.03
Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment Pharmacol Ther (2009) 1.02
Synthesis of glycosylated haemoglobin in vivo. Diabetologia (1981) 1.02
Time-resolved holography with photoelectrons. Science (2010) 1.02
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract (2011) 1.01
The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart: a randomized, glucose clamp, crossover study. Diabetes Technol Ther (2008) 1.01
Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. Am J Physiol (1999) 1.01
Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults. J Clin Endocrinol Metab (2001) 1.00
Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol (1998) 1.00
Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99
Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab (2000) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int (1986) 0.99
The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia (1981) 0.99
Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism (2000) 0.99
Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans. J Clin Endocrinol Metab (2007) 0.99
Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest (1993) 0.97
Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study. Clin Endocrinol (Oxf) (1995) 0.96
The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab (2000) 0.96
Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices. J Clin Endocrinol Metab (1990) 0.96
Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab (1989) 0.96
An evaluation of the relationship between adult height and health-related quality of life in the general UK population. Clin Endocrinol (Oxf) (2007) 0.95
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. J Clin Endocrinol Metab (2000) 0.95
Metabolic efficacy of preprandial administration of Lys(B28), Pro(B29) human insulin analog in IDDM patients. A comparison with human regular insulin during a three-meal test period. Diabetes Care (1997) 0.94
The ghrelin response to exercise before and after growth hormone administration. J Clin Endocrinol Metab (2006) 0.94
Adult growth hormone deficiency. Horm Res (1994) 0.93
The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. Diabetes (2001) 0.93
Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med (2006) 0.93
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries. Diabetes Obes Metab (2012) 0.93
Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest (1981) 0.93
Prognosis for juvenile diabetics with nephropathy and failing renal function. Acta Med Scand (1978) 0.92
Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabet Med (1988) 0.92
Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. J Clin Endocrinol Metab (1998) 0.92
International survey of insulin pump users: Impact of continuous subcutaneous insulin infusion therapy on glucose control and quality of life. Prim Care Diabetes (2007) 0.92
Increased myocardial contractility following growth hormone administration in normal man. An echocardiographic study. Dan Med Bull (1988) 0.91
Effect on renal haemodynamics, glomerular filtration rate and albumin excretion of high oral protein load. Scand J Clin Lab Invest (1986) 0.91
The relationship between pregnancy, HCS and B lymphocytes. Acta Pathol Microbiol Scand C (1976) 0.90
Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab (1996) 0.90
Subcutaneous degradation of insulin. Diabetologia (1981) 0.90
Functional and morphological renal manifestations in diabetes mellitus. Diabetologia (1981) 0.89
High harmonic spectroscopy of multichannel dynamics in strong-field ionization. Phys Rev Lett (2010) 0.89
Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. J Clin Endocrinol Metab (1995) 0.88
Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients. J Clin Endocrinol Metab (1995) 0.88
Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care (1979) 0.88
Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. J Clin Endocrinol Metab (2001) 0.88
B, T and null lymphocytes in newborn infants and their mothers. Acta Paediatr Scand (1976) 0.88
Effects of growth hormone on glucose metabolism. Horm Res (1991) 0.88